Clinical Trials Directory

Trials / Completed

CompletedNCT02354300

Transcranial Doppler Ultrasound Monitoring During Flow-Diverter Embolization

A Prospective Study of the Treatment of Intracranial Aneurysms Using Pipeline Flow-Diverter Embolization in Conjunction With Transcranial Dopplers (TCD)

Status
Completed
Phase
Study type
Observational
Enrollment
2 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Flow diverters have been approved since 2012 for the treatment of large, wide neck intracranial aneurysms. These devices have been associated with embolic events which cause blockage in a blood vessel and can result in long term complications. One possible cause of these events is the formation of small emboli during placement of the device.

Detailed description

Flow diverters have been developed to treat intracranial aneurysms. Embolisms have occurred in a small percentage of patients which can result in long term complications including stroke, hemorrhage, and even death. The formation of microemboli during the insertion of the device has not been evaluated. During insertion, there is significant disruption of blood flow and this may be a source of intracranial microemboli. This study will use transcranial doppler ultrasound (TCD) to evaluate the blood flow during the placement of flow diverters to try to determine why these embolic events occur.

Conditions

Interventions

TypeNameDescription
DEVICETCD UltrasoundTranscranial doppler ultrasound monitoring will occur during flow diverter placement.

Timeline

Start date
2015-04-01
Primary completion
2015-04-01
Completion
2015-05-01
First posted
2015-02-03
Last updated
2016-08-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02354300. Inclusion in this directory is not an endorsement.